ROP logo

Roche Holding AG Stock Price

SWX:ROP Community·CHF 257.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ROP Share Price Performance

CHF 323.90
0.00 (0.00%)
CHF 323.90
0.00 (0.00%)
Price CHF 323.90

ROP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with adequate balance sheet.

2 Risks
3 Rewards

Roche Holding AG Key Details

CHF 63.4b

Revenue

CHF 16.2b

Cost of Revenue

CHF 47.2b

Gross Profit

CHF 34.3b

Other Expenses

CHF 12.9b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 23, 2026
16.19
74.49%
20.33%
83.5%
View Full Analysis

About ROP

Founded
1896
Employees
103249
CEO
Thomas Schinecker
WebsiteView website
www.roche.com

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Recent ROP News & Updates

Recent updates

No updates